A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions

Endocrinology

Volumn 139, Issue 10, 1998, Pages 4182-4188

  Rees, C ^a   Clemmons, D R ^a   Horvitz, G D ^a   Clarke, J B ^a   Busby, W H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MIGRATION; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; SWINE;

EID: 0031733294     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.10.6266     Document Type: Article

References (33)

1. Bennett MR, Evan GI, Schwartz SM 1995 Aproptosis of human vascular smooth muscle cells derived from normal vessel and coronary atherosclerotic plaques. J Clin Invest 95:2266-2274
2. Ross R 1995 Cell biology of atherosclerosis. Annu Rev Physiol 57:791-804
3. Cohick WS, Gockerman A, Clemmons DR 1995 Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and IGFs is enhanced by serum deprivation in vascular growth muscle cells. J Cell Physiol 164:187-196
4. Duan C, Hawes S, Prevette T, Clemmons DR 1996 Insulin-like growth factor-I (IGF-I) stimulates IGF binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem 271:4280-4288
5. Giannella-Neto D, Kamyar A, Sharifi B, Pirola J, Kupfer J, Rosenfeld RG, Forrester JS, Fagin JA 1992 Platelet-derived growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4. Circ Res 71:646-656
6. Gockerman A, Clemmons DR 1995 Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2. Circ Res 76:514-521
7. Parker A, Gockerman A, Busby WH, Clemmons DR 1995 Properties of an insulin-like growth factor binding protein 4 protease that is secreted by smooth muscle cells. Endocrinology 135:2470-2476
8. Imai Y, Busby WH, Smith CE, Clark JB, Horvitz GD, Rees C, Clemmons DR 1997 Protease resistant form of insulin-like growth factor binding protein-5 is an inhibitor of insulin-like growth factor-I actions in porcine smooth muscle cells in culture. J Clin Invest 100:2596-2605
9. Chernausek SD, Smith CE, Duffin KL, Busby WH, Wright G, Clemmons DR 1995 Proteolytic cleavage of insulin-like growth factor binding protein-4 (IGFBP-4). J Biol Chem 270:11377-11382
10. Conover CA, Durham SK, Zapf J, Masiarz FR, Keifer MC 1995 Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF binding protein-4 proteolysis and expression of protease-resistant IGF binding protein-4 mutants. J Biol Chem 270:4395-4400
11. Cohick WS, Gockerman A, Clemmons DR 1993 Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors. J Cell Physiol 157:52-60
12. Ross R 1971 The smooth muscle cell: growth of smooth muscle in cultures and formation of elastic fibers. J Cell Biol 50:172-186
13. McCusker RH, Camacho-Hubner C, Clemmons DR 1989 Identification of the types of insulin-like growth factor binding proteins that are secreted by muscle cells in vitro. J Biol Chem 264:7795-7800
14. Busby WH, Klapper DG, Clemmons DR 1988 Purification of a 31000 dalton insulin-like growth factor binding protein from human amniotic fluid. J Biol Chem 263:14203-14210
15. Camacho-Hubner C, Busby WH, McCusker RH, Wright G, Clemmons DR 1992 Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem 267:11949-11956
16. Parker A, Busby WH, Clemmons DR 1996 Identification of the extracellular matrix binding site for insulin-like growth factor binding protein-5. J Biol Chem 271:13523-13529
17. Arai T, Clarke JB, Parker A, Busby Jr W, Nam TJ, Clemmons DR 1996 Substitution of specific amino acids in insulin-like growth factor binding protein-5 alters heparin binding and its change in affinity for IGF-I in response to heparin. J Biol Chem 271:6099-6106
18. Dong Y, Skoulteki A, Pollard J 1993 Efficient DNA transfection of quiescent mammalian cells. Nucleic Acids Res 21:1771-1772
19. Sanger F, Nicklen S, Coulson AR 1977 DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467
20. Fowlkes J, Freemark M 1992 Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF binding protein-4 in dermal fibroblasts. Endocrinology 131:2071-2076
21. Clemmons DR, Gardner LI 1990 A factor contained in plasma is required for IGF binding protein-1 to potentiate the effect of IGF-I on smooth muscle cell DNA synthesis. J Cell Physiol 145:129-135
22. Jones JI, Prevette T, Gockerman A, Clemmons DR 1996 Binding of vitronectin to an aVB3 integrin is necessary for smooth muscle cells to migrate in response to IGF-I. Proc Natl Acad Sci 93:2462-2467
23. Conover CA, Keifer MC, Zapf J 1993 Posttranslational regulation of insulin-like growth factor binding protein 4 in normal and transformed human fibroblasts. J Clin Invest 91:1129-1137
24. Myers SE, Cheung PT, Handwerger SH, Chernausek SD 1993 Insulin-like growth factor I enhanced proteolysis of IGF binding protein-4 in conditioned medium from primary cultures of human decidua. Endocrinology 133: 1525-1531
25. Kamyar A, Pirola CJ, Wang HM, Sharifi B, Mohan S, Forrester JS, Fagin JA 1994 Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor binding protein-4 are regulated by cell confluence in vascular smooth muscle cells. Circ Res 74:576-585
26. Durham SK, Keifer MR, Riggs BL, Conover CA 1994 Regulation of insulin-like growth factor binding protein-4 by a specific insulin-like growth factor binding protein-4 protease in normal human osteoblast like cells. Implications on human cell physiology. J Bone Miner Res 9:111-117
27. Kanzaki S, Hilliker S, Baylink DJ, Mohan S 1994 Evidence that human bone cells in culture produce insulin-like growth factor binding protein-4 and -5 proteases. Endocrinology 134:383-392
28. Wang J, Wen N, Witte DP, Chernausek SD, Nikiforov YE, Clemens TL, Sharifi B, Strauch AR, Fagin JA 1998 Overexpression of IGFBP-4 in smooth muscle cells of transgenic mice through a smooth muscle α actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology 139:2605-2614
29. Khorsondi MJ, Fagin JA, Ginnella-Neto JC, Forrester JS, Cercek B 1992 Regulation of insulin-like growth factor I and its receptor in rat aorta after balloon degradation: evidence for local bioactivity. J Clin Invest 90:1926-1931
30. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ 1994 Localization of insulin-like growth factor-I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. Circulation 89:1511-1517
31. Gockerman A, Jones JI, Prevette T, Clemmons DR 1995 Insulin-like growth factor binding protein-2 inhibits smooth muscle cell migration response to IGF-I. Endocrinology 136:4168-4173
32. Jones JI, Gockerman A, Busby WH, Camacho-Hubner C, Clemmons DR 1993 Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 121:679-687
33. Duan C, Clemmons DR 1998 Differential expression and opposing biological effects of insulin-like growth factor (IGF) binding proteins-4 and -5 in vascular smooth muscle cells. J Biol Chem 273:16836-16842